ConductScience.org, home

Paper26972772

NKT cell subsets as key participants in liver physiology and pathology.

Bandyopadhyay K and 2 others. Cell Mol Immunol, 2016. Cited by 155 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. NKT cell subsets as key participants in liver physiology and pathology. Papers, record 26972772. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26972772

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
NKT cell subsets as key participants in liver physiology and pathology.
PubMed
Journal
Cell Mol Immunol
PubMed
Year
2016
PubMed
Publication types
Journal Article, Review, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
155
iCite
Relative citation ratio, by iCite
4.58
iCite
Revised in PubMed
2026-11-02
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bandyopadhyay KKeya
2Marrero IIdania
3Kumar VVipin

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LiverMajor topic
Lymphocyte SubsetsMajor topic
Natural Killer T-CellsMajor topic
Animals
Antigens
Humans
Lymphocyte Activation

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AA020864NIAAA NIH HHSUnited StatesR01AA020864PubMed and NIHNIH RePORTER
R01CA100660NIHNIH RePORTER

References124

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122,251,704Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice.J Clin Invest2012https://conductscience.org/library/papers/22251704PubMed
220,034,047Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis.Hepatology2010https://conductscience.org/library/papers/20034047PubMed
316,175,608Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease.Hepatology2005https://conductscience.org/library/papers/16175608PubMed
419,342,695Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors.J Immunol2009https://conductscience.org/library/papers/19342695PubMed
520,139,988Raising the NKT cell family.Nat Immunol2010https://conductscience.org/library/papers/20139988PubMed
626,136,748Type II NKT Cells in Inflammation, Autoimmunity, Microbial Immunity, and Cancer.Front Immunol2015https://conductscience.org/library/papers/26136748PubMed
719,592,275Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.Immunity2009https://conductscience.org/library/papers/19592275PubMed
822,820,603Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor.Nat Immunol2012https://conductscience.org/library/papers/22820603PubMed
924,166,975Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice.J Immunol2013https://conductscience.org/library/papers/24166975PubMed
1019,556,980A cell biological view of Toll-like receptor function: regulation through compartmentalization.Nat Rev Immunol2009https://conductscience.org/library/papers/19556980PubMed
1125,661,730Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration.Cell Mol Immunol2016https://conductscience.org/library/papers/25661730PubMed
1220,950,612Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice.Gastroenterology2011https://conductscience.org/library/papers/20950612PubMed
1321,740,985Role of NKT cells in autoimmune liver disease.Autoimmun Rev2011https://conductscience.org/library/papers/21740985PubMed
1412,368,312Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.J Virol2002https://conductscience.org/library/papers/12368312PubMed
1519,201,769Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.Gut2009https://conductscience.org/library/papers/19201769PubMed
1624,260,285Cross-activating invariant NKT cells and kupffer cells suppress cholestatic liver injury in a mouse model of biliary obstruction.PLoS One2013https://conductscience.org/library/papers/24260285PubMed
1718,471,544Cellular and molecular mechanisms of liver injury.Gastroenterology2008https://conductscience.org/library/papers/18471544PubMed
1823,296,703Tim-3/galectin-9 regulate the homeostasis of hepatic NKT cells in a murine model of nonalcoholic fatty liver disease.J Immunol2013https://conductscience.org/library/papers/23296703PubMed
1918,981,087Cutting edge: Programmed death-1/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy.J Immunol2008https://conductscience.org/library/papers/18981087PubMed
2020,228,796An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells.Nat Immunol2010https://conductscience.org/library/papers/20228796PubMed

See all 124 references

Cited by118

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 155 citations.

PMIDTitleJournalYearIn PapersSource
42,855,466Microbial cues and T cell immunity: deciphering their interactions in chronic liver disease.Exp Mol Med2026https://conductscience.org/library/papers/42855466PubMed
42,708,866The Defect of iNKT Cells Mediates Mitochondrial Dysfunction Through IL-6/STAT3 Signaling to Induce Atrial Inflammation and Fibrosis to Aggravate Postoperative Atrial Fibrillation.Physiol Res2026https://conductscience.org/library/papers/42708866PubMed
42,601,419Detection of Natural Killer and Natural Killer T Cells Responses among Patients with Chronic Hepatitis C Infections in Sana'a City-Yemen.Curr Microbiol2026https://conductscience.org/library/papers/42601419PubMed
42,432,768The diversity of STING in regulating immune cell function and its role in liver diseases: from bench to bedside.Cell Biosci2026https://conductscience.org/library/papers/42432768PubMed
42,358,991Integrated single-cell and spatial transcriptomics reveal immune landscape and NKT-Th1 signatures in colorectal cancer.Front Immunol2026https://conductscience.org/library/papers/42358991PubMed
42,353,388The Pro-Inflammatory Action of Different Pathogen-Associated Molecular Patterns in Porcine Hepatic and Intestinal Cell Cultures.Animals (Basel)2026https://conductscience.org/library/papers/42353388PubMed
42,148,091The immunometabolic nature of MASH: framing immune cells within metabolic dysfunction.Front Immunol2026https://conductscience.org/library/papers/42148091PubMed
42,064,073Immune cells in liver injury: from pathogenic mechanisms to immunotherapy.Front Immunol2026https://conductscience.org/library/papers/42064073PubMed
41,903,685Conserved Ductular Reaction Mechanisms in Biliary Atresia and Primary Sclerosing Cholangitis Derived From Single-Cell and Spatial Transcriptomics.Cell Mol Gastroenterol Hepatol2026https://conductscience.org/library/papers/41903685PubMed
41,821,922Hepatic Viral Reservoirs in Concurrent HIV and HBV: From Mechanistic Insight to Integrated Cure Strategies.Infect Drug Resist2026https://conductscience.org/library/papers/41821922PubMed
41,543,487Natural Killer T cells promote cholestatic liver disease independent of antigen presentation by cholangiocytes.Hepatol Commun2026https://conductscience.org/library/papers/41543487PubMed
41,492,190Clinical applications of immunogenomics in hepatocellular carcinoma.Clin Mol Hepatol2026https://conductscience.org/library/papers/41492190PubMed
41,160,198Functions and clinical implications of the liver microenvironment in hepatic uveal melanoma metastases.Cancer Metastasis Rev2025https://conductscience.org/library/papers/41160198PubMed
41,136,986Characterizing immune profiles in hepatocellular carcinoma patients benefiting from pembrolizumab and lenvatinib using machine learning.BMC Cancer2025https://conductscience.org/library/papers/41136986PubMed
40,747,238Liver immunology: Biological role and clinical significance.World J Hepatol2025https://conductscience.org/library/papers/40747238PubMed
40,600,791Kupffer Cells Regulate iNKT Cells Through Il-12 to Mitigate the Extent of APAP-Induced Damage in the Liver.J Cell Mol Med2025https://conductscience.org/library/papers/40600791PubMed
40,520,296Association between atherogenic index of plasma and physical dysfunction: a cross-sectional study of middle-aged and older adults in China.Front Public Health2025https://conductscience.org/library/papers/40520296PubMed
40,512,622De-coupling immune parameters and toxicity associated with IL-12 agonism.Cell Rep2025https://conductscience.org/library/papers/40512622PubMed
40,461,700Liver macrophages: development, dynamics, and functions.Cell Mol Immunol2025https://conductscience.org/library/papers/40461700PubMed
40,330,481Coinfection with HIV-1 skews iNKT cells toward TCR anergy and limited expansion potential in people with hepatitis C.Front Immunol2025https://conductscience.org/library/papers/40330481PubMed

See all 118 cited by

Genes20

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CCL46,351PubTator's text mininghttps://conductscience.org/library/genes/6351NCBI Gene
CD1D912PubTator's text mininghttps://conductscience.org/library/genes/912NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CXCR13,577PubTator's text mininghttps://conductscience.org/library/genes/3577NCBI Gene
FAS355PubTator's text mininghttps://conductscience.org/library/genes/355NCBI Gene
IFNG3,458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL12B3,593PubTator's text mininghttps://conductscience.org/library/genes/3593NCBI Gene
IL17A3,605PubTator's text mininghttps://conductscience.org/library/genes/3605NCBI Gene
IL1B3,553PubTator's text mininghttps://conductscience.org/library/genes/3553NCBI Gene
IL2250,616PubTator's text mininghttps://conductscience.org/library/genes/50616NCBI Gene
IL63,569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
KLRB13,820PubTator's text mininghttps://conductscience.org/library/genes/3820NCBI Gene
KLRK122,914PubTator's text mininghttps://conductscience.org/library/genes/22914NCBI Gene
LGALS93,965PubTator's text mininghttps://conductscience.org/library/genes/3965NCBI Gene
NCAM14,684PubTator's text mininghttps://conductscience.org/library/genes/4684NCBI Gene
STAT16,772PubTator's text mininghttps://conductscience.org/library/genes/6772NCBI Gene
TLR47,099PubTator's text mininghttps://conductscience.org/library/genes/7099NCBI Gene
TNF7,124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene
TRBV20OR9-26,962PubTator's text mininghttps://conductscience.org/library/genes/6962NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26972772

GET https://conductscience.org/api/papers/v1/26972772/references?page=2